Leuthold Group, LLC Quest Diagnostics Inc Transaction History

Leuthold Group, LLC

$799 Million
Q4 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$140.36 - $173.01 $2.86 Million - $3.53 Million	-20,410 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$132.95 - $158.0 $8,508 - $10,112	64 Added 0.31%	20,410 $2.97 Million
Q2 2021 Aug 13, 2021	SELL	$126.66 - $141.48 $44,837 - $50,083	-354 Reduced 1.71%	20,346 $2.69 Million
Q1 2021 May 17, 2021	SELL	$114.63 - $133.34 $548,733 - $638,298	-4,787 Reduced 18.78%	20,700 $2.66 Million
Q4 2020 Feb 16, 2021	SELL	$112.7 - $128.05 $121,941 - $138,550	-1,082 Reduced 4.07%	25,487 $3.04 Million
Q3 2020 Nov 16, 2020	SELL	$107.05 - $130.01 $58,663 - $71,245	-548 Reduced 2.02%	26,569 $3.04 Million
Q2 2020 Aug 14, 2020	SELL	$73.34 - $122.61 $54,931 - $91,834	-749 Reduced 2.69%	27,117 $3.09 Million
Q1 2020 May 15, 2020	BUY	$75.14 - $115.68 $1.84 Million - $2.84 Million	24,532 Added 735.81%	27,866 $2.24 Million
Q4 2019 Feb 14, 2020	BUY	$100.29 - $107.99 $334,366 - $360,038	3,334 New	3,334 $356,000
Q2 2019 Aug 14, 2019	SELL	$85.18 - $101.94 $4.51 Million - $5.4 Million	-53,005 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$80.68 - $89.92 $190,969 - $212,840	-2,367 Reduced 4.27%	53,005 $4.77 Million
Q4 2018 Feb 14, 2019	SELL	$79.75 - $108.38 $530,337 - $720,727	-6,650 Reduced 10.72%	55,372 $4.61 Million
Q3 2018 Nov 14, 2018	SELL	$105.42 - $114.99 $119,651 - $130,513	-1,135 Reduced 1.8%	62,022 $6.69 Million
Q2 2018 Aug 14, 2018	SELL	$97.35 - $113.14 $7,495 - $8,711	-77 Reduced 0.12%	63,157 $6.94 Million
Q1 2018 May 15, 2018	BUY	$96.42 - $107.88 $6.1 Million - $6.82 Million	63,234 New	63,234 $6.34 Million

Others Institutions Holding DGX

# of Institutions

983

Shares Held

98.5M

Call Options Held

417K

Put Options Held

227K

View Full List

About QUEST DIAGNOSTICS INC

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

More about DGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Leuthold Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leuthold Group, LLC with notifications on news.

Account